BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 29987599)

  • 1. Reducing Breast Cancer-Related Lymphedema (BCRL) Through Prospective Surveillance Monitoring Using Bioimpedance Spectroscopy (BIS) and Patient Directed Self-Interventions.
    Kilgore LJ; Korentager SS; Hangge AN; Amin AL; Balanoff CR; Larson KE; Mitchell MP; Chen JG; Burgen E; Khan QJ; O'Dea AP; Nye L; Sharma P; Wagner JL
    Ann Surg Oncol; 2018 Oct; 25(10):2948-2952. PubMed ID: 29987599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of bioimpedance spectroscopy in the prevention of chronic breast cancer-related lymphedema.
    Kaufman DI; Shah C; Vicini FA; Rizzi M
    Breast Cancer Res Treat; 2017 Dec; 166(3):809-815. PubMed ID: 28831632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is bioimpedance spectroscopy a useful tool for objectively assessing lymphovenous bypass surgical outcomes in breast cancer-related lymphedema?
    Sutherland A; Wagner JL; Korentager S; Butterworth J; Amin AL; Balanoff CR; Hangge A; Larson KE
    Breast Cancer Res Treat; 2021 Feb; 186(1):1-6. PubMed ID: 33392840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing chronic breast cancer-related lymphedema utilizing a program of prospective surveillance with bioimpedance spectroscopy.
    Whitworth PW; Cooper A
    Breast J; 2018 Jan; 24(1):62-65. PubMed ID: 29063664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of Bioimpedance Spectroscopy with Risk Factors for the Development of Breast Cancer-Related Lymphedema.
    Vicini F; Shah C; Whitworth P; Walker M; Shi J
    Lymphat Res Biol; 2018 Dec; 16(6):533-537. PubMed ID: 30133336
    [No Abstract]   [Full Text] [Related]  

  • 6. Breast Cancer-Related Lymphedema (BCRL) and Bioimpedance Spectroscopy: Long-Term Follow-Up, Surveillance Recommendations, and Multidisciplinary Risk Factors.
    Jeffers EJ; Wagner JL; Korentager SS; Larson KE; Balanoff CR; Baker J; Chollet-Hinton L; Kilgore LJ
    Ann Surg Oncol; 2023 Oct; 30(10):6258-6265. PubMed ID: 37535267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational study.
    Soran A; Ozmen T; McGuire KP; Diego EJ; McAuliffe PF; Bonaventura M; Ahrendt GM; DeGore L; Johnson R
    Lymphat Res Biol; 2014 Dec; 12(4):289-94. PubMed ID: 25495384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioimpedance spectroscopy for breast cancer-related lymphedema assessment: clinical practice guidelines.
    Shah C; Whitworth P; Valente S; Schwarz GS; Kruse M; Kohli M; Brownson K; Lawson L; Dupree B; Vicini FA
    Breast Cancer Res Treat; 2023 Feb; 198(1):1-9. PubMed ID: 36566297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental and Analytical Comparisons of Tissue Dielectric Constant (TDC) and Bioimpedance Spectroscopy (BIS) in Assessment of Early Arm Lymphedema in Breast Cancer Patients after Axillary Surgery and Radiotherapy.
    Lahtinen T; Seppälä J; Viren T; Johansson K
    Lymphat Res Biol; 2015 Sep; 13(3):176-85. PubMed ID: 26305554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comparison of Bioimpedance Spectroscopy or Tape Measure Triggered Compression Intervention in Chronic Breast Cancer Lymphedema Prevention.
    Ridner SH; Dietrich MS; Boyages J; Koelmeyer L; Elder E; Hughes TM; French J; Ngui N; Hsu J; Abramson VG; Moore A; Shah C
    Lymphat Res Biol; 2022 Dec; 20(6):618-628. PubMed ID: 35099283
    [No Abstract]   [Full Text] [Related]  

  • 11. The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study.
    Zou L; Liu FH; Shen PP; Hu Y; Liu XQ; Xu YY; Pen QL; Wang B; Zhu YQ; Tian Y
    Breast Cancer; 2018 May; 25(3):309-314. PubMed ID: 29397555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for breast cancer-related lymphedema in patients undergoing 3 years of prospective surveillance with intervention.
    Koelmeyer LA; Gaitatzis K; Dietrich MS; Shah CS; Boyages J; McLaughlin SA; Taback B; Stolldorf DP; Elder E; Hughes TM; French JR; Ngui N; Hsu JM; Moore A; Ridner SH
    Cancer; 2022 Sep; 128(18):3408-3415. PubMed ID: 35797441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of monitoring techniques on progression to chronic breast cancer-related lymphedema: a meta-analysis comparing bioimpedance spectroscopy versus circumferential measurements.
    Shah C; Zambelli-Weiner A; Delgado N; Sier A; Bauserman R; Nelms J
    Breast Cancer Res Treat; 2021 Feb; 185(3):709-740. PubMed ID: 33245458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer-related arm lymphedema: incidence rates, diagnostic techniques, optimal management and risk reduction strategies.
    Shah C; Vicini FA
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):907-14. PubMed ID: 21945108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding breast cancer-related lymphoedema.
    Bennett Britton TM; Purushotham AD
    Surgeon; 2009 Apr; 7(2):120-4. PubMed ID: 19408805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing rates of chronic breast cancer-related lymphedema with screening and early intervention: an update of recent data.
    Whitworth P; Vicini F; Valente SA; Brownson K; DuPree B; Kohli M; Lawson L; Shah C
    J Cancer Surviv; 2024 Apr; 18(2):344-351. PubMed ID: 35947288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant taxanes and the development of breast cancer-related arm lymphoedema.
    Cariati M; Bains SK; Grootendorst MR; Suyoi A; Peters AM; Mortimer P; Ellis P; Harries M; Van Hemelrijck M; Purushotham AD
    Br J Surg; 2015 Aug; 102(9):1071-8. PubMed ID: 26040263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast Cancer-Related Lymphedema Risk is Related to Multidisciplinary Treatment and Not Surgery Alone: Results from a Large Cohort Study.
    Nguyen TT; Hoskin TL; Habermann EB; Cheville AL; Boughey JC
    Ann Surg Oncol; 2017 Oct; 24(10):2972-2980. PubMed ID: 28766228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and risk factors for arm lymphedema after multimodal breast-conserving treatment of nodal positive breast Cancer - a long-term observation.
    Rupp J; Hadamitzky C; Henkenberens C; Christiansen H; Steinmann D; Bruns F
    Radiat Oncol; 2019 Mar; 14(1):39. PubMed ID: 30845971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph node status and breast cancer-related lymphedema.
    Purushotham AD; Bennett Britton TM; Klevesath MB; Chou P; Agbaje OF; Duffy SW
    Ann Surg; 2007 Jul; 246(1):42-5. PubMed ID: 17592289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.